Robert Bradway is Chief Executive Officer and President of Amgen Inc. (AMGN). The company reported total compensation of $24,693,120 for fiscal year 2025.
| Salary | $1,925,409 |
|---|---|
| Bonus | $0 |
| Stock awards | $12,599,589 |
| Option awards | $5,399,996 |
| Non-equity incentive plan | $3,907,000 |
| Pension and non-qualified deferred compensation | $0 |
| All other compensation | $861,126 |
| Total | $24,693,120 |
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed, without adjustment.
Cited to the compensation disclosure Amgen Inc. filed April 7, 2026, accession 0001193125-26-145588.
| Peer-group chief executive median | $25,615,653 |
|---|---|
| Difference from that median | $-922,532 |
| Percentile within the disclosed peer group | 50th |
| Peers with a disclosed figure | 10 |
Medians and percentiles are computed across the peer group Amgen Inc. discloses in its own compensation disclosure.
| Named executive officer | Role | FY2025 total |
|---|---|---|
| Robert Bradway this page | Chief Executive Officer and President | $24,693,120 |
| James Bradner | Executive Vice President, Research and Development | $8,639,867 |
| Peter Griffith | Executive Vice President and Chief Financial Officer | $8,610,887 |
| Murdo Gordon | Executive Vice President, Global Commercial Operations | $8,523,471 |
| David Reese | Executive Vice President and Chief Technology Officer | $8,290,308 |
The company's named executive officers for fiscal year 2025, and what it reported for each. See the full Amgen Inc. compensation brief.
Robert Bradway's compensation sits inside Amgen Inc.'s full executive and board picture — the peer group, pay against peers, incentive design and the board itself.